1. ScholarBank@NUS

Lingzhi Wang

rp05443

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
Main Affiliation
 
Faculty
 
Email
csiwl@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Date Issued:  [2000 TO 2009]
Author:  Lee, S.C.

Results 1-10 of 10 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
1Jul-2006A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancerSoo, R.A. ; Wang, L.Z. ; Tham, L.S.; Yong, W.P. ; Boyer, M.; Lim, H.L.; Lee, H.S.; Millward, M.; Liang, S.; Beale, P.; Lee, S.C. ; Goh, B.C.
2Jul-2008A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancersYong, W.-P. ; Wang, L.-Z. ; Tham, L.-S.; Wong, C.-I.; Lee, S.-C. ; Soo, R. ; Sukri, N.; Lee, H.-S.; Goh, B.-C.
3Oct-2006A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9Tham, L.-S.; Goh, B.-C.; Nafziger, A.; Guo, J.-Y. ; Wang, L.-Z. ; Soong, R. ; Lee, S.-C. 
4Dec-2008Does saturable formation of gemcitabine triphosphate occur in patients?Tham, L.-S.; Wang, L.-Z. ; Soo, R.A. ; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.; Holford, N.H.G.
51-Sep-2002Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategiesGoh, B.-C.; Lee, S.-C. ; Wang, L.-Z. ; Fan, L.; Guo, J.-Y. ; Lamba, J.; Schuetz, E.; Lim, R.; Lim, H.-L.; Ong, A.-B.; Lee, H.-S.
6Apr-2006Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drugTham, L.-S.; Lee, H.-S.; Wang, L. ; Yong, W.-P. ; Fan, L.; Ong, A.-B.; Sukri, N.; Soo, R. ; Lee, S.-C. ; Goh, B.-C.
71-Dec-2007Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4α, and constitutive androstane receptor with docetaxel pharmacokineticsTham, L.-S.; Holford, N.H.G.; Hor, S.-Y.; Tan, T. ; Wang, L. ; Lim, R.-C.; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.
81-Aug-2003Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group studySoo, R.A. ; Lim, H.L.; Wang, L.Z. ; Lee, H.S.; Millward, M.J.; Tok, L.T.; Lee, S.C. ; Lehnert, M.; Goh, B.C.
9Apr-2008PXR, CAR and HNF4α genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patientsHor, S.Y.; Lee, S.C. ; Wong, C.I.; Lim, Y.W.; Lim, R.C.; Wang, L.Z. ; Fan, L.; Guo, J.Y. ; Lee, H.S.; Goh, B.C.; Tan, T. 
102009Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effectWang, L.-Z. ; Yong, W.-P. ; Soo, R.-A. ; Lee, S.-C. ; Soong, R. ; Lee, H.-S.; Goh, B.-C.